Nih

Nih funding pages collect matching grants, scholarships, benefits, fellowships, and other programs from the FindMyMoney.App directory. Use this page to compare current opportunities, then verify deadlines and eligibility on the official source before applying.

RFA-NS-25-022: BRAIN Initiative UH3 Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System

NIH's BRAIN Initiative UH3 opportunity funds first-in-human and early clinical studies of next-generation CNS recording or stimulation devices that are ready for milestone-based advancement toward translation and clinical adoption.

Status: Open Type: Grant Amount: Estimated $10M per year for 5 to 7 awards; project period may not exceed 5 years Deadline: Sep 28, 2026 Location: United States

RFA-NS-25-023: HEAL Initiative Studies to Enable Analgesic Discovery (R61/R33, Clinical Trial Not Allowed)

NIH HEAL funds preclinical translational work to build stronger evidence for non-addictive analgesic discovery through a two-stage R61/R33 mechanism with no clinical trials and strict peer-review criteria.

Status: Open Type: Grant Amount: Estimated total $2,500,000 for 4-5 awards; direct costs up to $350,000 per year Deadline: Sep 17, 2026 Location: United States

RFA-NS-27-015: BRAIN Initiative Connectivity Across Scales (BRAIN CONNECTS): Specialized Projects for Scalable Technologies (U01 Clinical Trial Not Allowed)

NIH’s BRAIN Initiative NOFO supports U01 cooperative agreement projects that build scalable technologies for brain-wide connectivity mapping, with an expected first-year commitment of about $10M and roughly 3–6 awards expected.

Status: Open Type: Grant Amount: NIH estimates $10M in the first year to fund approximately 3–6 awards Deadline: Jul 9, 2026 Location: United States

RFA-OD-25-008: Tobacco Regulatory Science Small Grant Program for New Investigators (R03 Clinical Trial Optional)

NIH and FDA’s interagency Tobacco Regulatory Science Program runs R03 small grants for early-career investigators developing pilot studies and methods that can directly inform FDA tobacco product regulation.

Status: Open Type: Grant Amount: Up to $75,000 direct costs per year Deadline: Jul 14, 2026 Location: United States

RFA-OD-25-010: Resource-Related Research Projects for Development of Models and Related Materials for Studying Human Health and Diseases (R24 Clinical Trials Not Allowed)

NIH/ORIP’s NIH-wide R24 opportunity funds development and improvement of broadly useful biomedical models, methods, and biological materials that can serve multiple NIH Institutes and Centers across multiple organ systems.

Status: Open Type: Grant Amount: NIH intends to commit $5,000,000 per FY for FY 2026-2029 and fund at least six awards per fiscal … Deadline: Sep 28, 2026 Location: United States

RFA-OD-25-012: Informatics, Coordination and Service Center for the Mutant Mouse Resource and Research Centers (U42)

A U42 cooperative agreement that funds the Mutant Mouse Resource and Research Center Consortium’s Informatics, Coordination and Service Center through a multi-component application with review cycles in 2026 and funding decisions in 2026/2027.

Status: Deadline Passed Type: Grant Amount: No total program amount published; direct costs up to $650,000 per year Deadline: Jan 12, 2026 Location: United States

RFA-OD-27-003: INCLUDE Project: Exploratory/Developmental Research Awards for Down syndrome (R21 Clinical Trial Not Allowed)

This NIH NOFO funds high-risk, high-reward R21 projects focused on Down syndrome and co-occurring conditions through the INCLUDE Project in the 2026–2028 cycles.

Status: Open Type: Grant Amount: NIH intends to commit about $1,000,000 to fund up to 5 awards in FY2027–FY2029 Deadline: Oct 15, 2026 Location: United States

RFA-OD-27-004: INCLUDE Project Transformative Research Awards for Down syndrome (R01 Clinical Trial Not Allowed)

The NIH INCLUDE Project Transformative Research Awards program supports unusually innovative R01 applications focused on Down syndrome biology and co-occurring conditions with high-risk, high-reward approaches.

Status: Open Type: Grant Amount: NIH intends to commit about $3,000,000 to fund up to 4 awards per year Deadline: Oct 15, 2026 Location: United States

RFA-OD-27-005: INCLUDE Project: Clinical Trials Phased Awards for Down syndrome Research (R61/R33 Clinical Trial Required)

A trans-NIH R61/R33 phased mechanism for developing and advancing translational clinical trials for co-occurring conditions in people with Down syndrome, with a maximum five-year project period and an upcoming 2026/2027 filing rhythm.

Status: Open Type: Grant Deadline: Oct 15, 2026 Location: United States

RFA-OD-27-008: Maximizing the Scientific Value of ECHO Data (NRSA F32 Postdoctoral Fellowship)

A National Institutes of Health Office of the Director fellowship call for postdoctoral researchers using Environmental Influences on Child Health Outcomes (ECHO) de-identified cohort data through the NICHD DASH repository, with applications due in December 2026 for FY 2027 start cycles.

Status: Open Type: Grant Amount: Estimated total budget up to $1,260,000 across approximately 8 awards (FY 2027–2029, contingent … Deadline: Dec 2, 2026 Location: United States